Tag |
Content |
dbPAF ID |
dbPAF-0000061 |
Uniprot Accession |
O00300; TR11B_HUMAN; B2R9A8; O60236; Q53FX6; Q9UHP4; |
Genbank Protein ID |
NP_002537.3; |
Genbank Nucleotide ID |
NM_002546.3; |
Protein Name |
Tumor necrosis factor receptor superfamily member 11B |
Protein Synonyms/Alias |
Osteoclastogenesis inhibitory factor;Osteoprotegerin; |
Gene Name |
TNFRSF11B |
Gene Synonyms/Alias |
OCIF;OPG; |
Organism |
Homo sapiens(Human) |
NCBI Taxa ID |
9606 |
Functional Description (View all) |
Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.Functional Description
Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.
|
Phosphorylation Sites
|
dbPAF PTMs: 4 Position | Peptides | Source | References ( PMIDs ) |
---|
246 | RIKRQHSSQEQTFQL | PhosphoSitePlus | 22135298 | 360 | KTYHFPKTVTQSLKK | PhosphoSitePlus | 22135298 | 362 | YHFPKTVTQSLKKTI | PhosphoSitePlus | 22135298 | 364 | FPKTVTQSLKKTIRF | PhosphoSitePlus | 22135298 |
|
Sequence (Fasta) | MNNLLCCALV FLDISIKWTT QETFPPKYLH YDEETSHQLL CDKCPPGTYL KQHCTAKWKT 60 VCAPCPDHYY TDSWHTSDEC LYCSPVCKEL QYVKQECNRT HNRVCECKEG RYLEIEFCLK 120 HRSCPPGFGV VQAGTPERNT VCKRCPDGFF SNETSSKAPC RKHTNCSVFG LLLTQKGNAT 180 HDNICSGNSE STQKCGIDVT LCEEAFFRFA VPTKFTPNWL SVLVDNLPGT KVNAESVERI 240 KRQHSSQEQT FQLLKLWKHQ NKDQDIVKKI IQDIDLCENS VQRHIGHANL TFEQLRSLME 300 SLPGKKVGAE DIEKTIKACK PSDQILKLLS LWRIKNGDQD TLKGLMHALK HSKTYHFPKT 360 VTQSLKKTIR FLHSFTMYKL YQKLFLEMIG NQVQSVKISC L
402Fasta Sequence
>O00300|TNFRSF11B|Homo sapiens(Human) MNNLLCCALVFLDISIKWTTQETFPPKYLHYDEETSHQLLCDKCPPGTYLKQHCTAKWKTVCAPCPDHYYTDSWHTSDECLYCSPVCKELQYVKQECNRTHNRVCECKEGRYLEIEFCLKHRSCPPGFGVVQAGTPERNTVCKRCPDGFFSNETSSKAPCRKHTNCSVFGLLLTQKGNATHDNICSGNSESTQKCGIDVTLCEEAFFRFAVPTKFTPNWLSVLVDNLPGTKVNAESVERIKRQHSSQEQTFQLLKLWKHQNKDQDIVKKIIQDIDLCENSVQRHIGHANLTFEQLRSLMESLPGKKVGAEDIEKTIKACKPSDQILKLLSLWRIKNGDQDTLKGLMHALKHSKTYHFPKTVTQSLKKTIRFLHSFTMYKLYQKLFLEMIGNQVQSVKISCL
|
Keyword |
KW-0002--3D-structure KW-0053--Apoptosis KW-0181--Complete proteome KW-0903--Direct protein sequencing KW-0225--Disease mutation KW-1015--Disulfide bond KW-0325--Glycoprotein KW-0621--Polymorphism KW-0675--Receptor KW-1185--Reference proteome KW-0677--Repeat KW-0964--Secreted KW-0732--Signal
|
Interpro |
IPR011029--DEATH-like_dom IPR000488--Death_domain IPR001368--TNFR/NGFR_Cys_rich_reg IPR022323--TNFR_11 IPR017371--TNFR_11B
|
PROSITE |
PS00652--TNFR_NGFR_1 PS50050--TNFR_NGFR_2
|
Pfam |
PF00531--Death PF00020--TNFR_c6
|
Gene Ontology |
GO:0005576--C:extracellular region GO:0005615--C:extracellular space GO:0005887--C:integral component of plasma membrane GO:0005886--C:plasma membrane GO:0005578--C:proteinaceous extracellular matrix GO:0005125--F:cytokine activity GO:0004872--F:receptor activity GO:0005031--F:tumor necrosis factor-activated receptor activity GO:0097190--P:apoptotic signaling pathway GO:0030198--P:extracellular matrix organization GO:0006955--P:immune response GO:0006954--P:inflammatory response GO:0045779--P:negative regulation of bone resorption GO:0042489--P:negative regulation of odontogenesis of dentin-containing tooth GO:0043410--P:positive regulation of MAPK cascade GO:0042981--P:regulation of apoptotic process GO:0042127--P:regulation of cell proliferation GO:0046685--P:response to arsenic-containing substance GO:0042493--P:response to drug GO:0043627--P:response to estrogen GO:0032496--P:response to lipopolysaccharide GO:0032026--P:response to magnesium ion GO:0007584--P:response to nutrient GO:0007165--P:signal transduction GO:0001501--P:skeletal system development GO:0033209--P:tumor necrosis factor-mediated signaling pathway
|